Comparison of Humira biosimilars in the US and Europe
Pharmaceutical Technology
MARCH 24, 2023
Biosimilars are an important tool to facilitate competition, lower the price of drugs, and create savings across the board. Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. The biosimilar market in the US may progress differently this time.
Let's personalize your content